STOCK TITAN

Centene Corp Del SEC Filings

CNC NYSE

Welcome to our dedicated page for Centene Del SEC filings (Ticker: CNC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

This page provides access to Centene Corporation (NYSE: CNC) SEC filings, offering insight into the company’s regulatory disclosures, financial communications, and governance updates. As a healthcare enterprise focused on government-sponsored and commercial healthcare programs, Centene uses filings such as Form 8-K to inform investors about material events, earnings information, and board changes.

Recent 8-K filings describe Centene’s participation in healthcare investor conferences, where management discusses the company’s financial outlook and the use of non-GAAP financial measures like adjusted diluted earnings per share. Other 8-Ks report quarterly financial results, the withdrawal or update of earnings guidance, and the resignation of directors along with resulting changes in the size of the board. These documents help investors understand how Centene evaluates its performance, plans operations, and manages corporate governance.

Through this filings page, users can review Centene’s current and historical submissions to the U.S. Securities and Exchange Commission, including annual and quarterly reports when available, as well as event-driven filings. Real-time updates from EDGAR are combined with AI-powered summaries that explain the key points of complex documents, helping readers interpret financial metrics, non-GAAP reconciliations, and narrative disclosures without wading through every page.

In addition to financial information, Centene’s filings may address topics such as regulatory considerations, risk factors related to government healthcare programs, and the company’s approach to non-GAAP reporting. For investors tracking CNC, this page serves as a central location to monitor new filings, understand the context of earnings announcements, and follow changes in leadership or guidance as they are formally reported to the SEC.

Rhea-AI Summary

Tanji Kenneth, a director of Centene Corp (CNC), reported an acquisition of 803 shares of common stock on 09/30/2025 under Form 4. The shares were reported with a transaction code A (acquisition) and a reported price of $0. Following the reported transaction, Mr. Kenneth beneficially owns 5,948 shares in total, which includes 3,579 restricted stock units that remain subject to vesting. The filing was executed by attorney-in-fact Christopher A. Koster and signed on 10/01/2025. The ownership is reported as direct.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.17%
Tags
insider
-
Rhea-AI Summary

Kenneth A. Burdick, a director of Centene Corp (CNC), reported an acquisition and existing holdings. On 09/30/2025 he was credited with 852 shares of Common Stock at a price of $0, bringing his reported total direct beneficial ownership to 338,371.924 shares (this total includes 3,579 restricted stock units subject to vesting). The filing also discloses 86,498 shares held indirectly by Burdick Family LLC, of which he is a chief manager and for which he disclaims beneficial ownership except to the extent of pecuniary interest. Separately, the report shows a 10,000-share option exercisable from 02/07/2025 through 02/07/2032 with a strike of $80.57.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.17%
Tags
insider
-
Rhea-AI Summary

Form 144 filed for Centene Corporation (CNC) proposing the sale of 10,775 common shares through Merrill (10800 N Michigan Rd, Zionsville, IN) with an aggregate market value of $314,545.10. The filing lists 491,133,000 shares outstanding and an approximate sale date of 09/09/2025. The shares to be sold were acquired as stock bonuses on multiple dates between 03/31/2022 and 05/13/2025 from Wayne S. DeVeydt and total exactly 10,775 shares. The filer certifies they have no undisclosed material adverse information about the issuer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Centene Corporation disclosed that Director Thomas R. Greco notified the company on August 12, 2025 that he will resign effective August 22, 2025 due to increased professional responsibilities after his appointment as chief executive officer of FleetPride, Inc., a privately-held automotive parts company. The filing states his resignation was not the result of any dispute or disagreement with Centene or its Board. The Board has reduced its size to nine directors effective upon his resignation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Harris Associates L.P. and Harris Associates, Inc. file Amendment No. 1 to a Schedule 13G reporting ownership in Centene Corp. The filing shows Harris beneficially owns 20,418,731 shares of Centene common stock, representing 4.1% of the class. Harris reports sole voting power for 18,043,616 shares and sole dispositive power for 20,418,731 shares. The filing states these shares are held in the ordinary course of business and not for the purpose of changing control. The document identifies the filing parties, addresses, CUSIP 15135B101, and includes certifications and signatures dated 08/14/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Centene director Kenneth A. Burdick filed an amended Initial Statement of Beneficial Ownership to correct previously reported holdings. The Form 3/A reports 360,802 shares of Centene (CNC) and states the original Form 3 filed on 01/14/2022 and subsequent Form 4s overstated his direct holdings by 29,533 shares. The event date listed is 01/05/2022 and the amendment was executed by an attorney-in-fact on 08/11/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Centene Corporation director and chief executive officer Sarah London reported an open-market purchase of common stock on 08/08/2025. The filing shows acquisition of 19,230 shares at a weighted average price of $25.49–$25.50, increasing her reported direct beneficial ownership to 845,275 shares. The ownership total explicitly includes 591,998 shares represented by previously-granted restricted stock units and performance stock units reported at target levels and subject to vesting.

The report also discloses 13,449 performance-style stock options with an exercise price of $81.85, tied to a grant with a performance condition that the common stock close at or above $100 for 20 consecutive trading days before they may become exercisable. The form was executed by an attorney-in-fact.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Centene Del (CNC)?

The current stock price of Centene Del (CNC) is $43.32 as of January 30, 2026.

What is the market cap of Centene Del (CNC)?

The market cap of Centene Del (CNC) is approximately 21.4B.
Centene Corp Del

NYSE:CNC

CNC Rankings

CNC Stock Data

21.43B
489.22M
0.46%
99.27%
3.96%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
ST LOUIS

CNC RSS Feed